Barbara Grohmann-Izay
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes, Cytokine Signaling Pathways and Interactions, Breast Cancer Treatment Studies, Acute Myeloid Leukemia Research
Most-Cited Works
- → Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study(2020)333 cited
- → Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo(2018)52 cited
- → Final Results from PROUD-PV a Randomized Controlled Phase 3 Trial Comparing Ropeginterferon Alfa-2b to Hydroxyurea in Polycythemia Vera Patients(2016)28 cited
- → Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial(2018)22 cited
- → Evidence for Superior Efficacy and Disease Modification after Three Years of Prospective Randomized Controlled Treatment of Polycythemia Vera Patients with Ropeginterferon Alfa-2b Vs. HU/BAT(2018)19 cited
- → Long-Term Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Polycythemia Vera — Final Phase I/II Peginvera Study Results(2018)16 cited
- → Correlation of the volume of ectopic pregnancy and MTX therapy outcome: a retrospective cohort study(2014)14 cited
- → Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults(2014)11 cited
- → Ropeginterferon Alfa-2b versus Standard Therapy for Polycythaemia Vera; a Randomised, Controlled, Phase III Trial(2019)7 cited
- → Morbidity reduction using the vessel sealing device LigaSure™ in breast cancer surgery(2015)5 cited